BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33641298)

  • 41. Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency.
    Mirsafian H; Ripen AM; Leong WM; Chear CT; Bin Mohamad S; Merican AF
    Sci Rep; 2017 Jul; 7(1):6836. PubMed ID: 28754963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults.
    Usui K; Sasahara Y; Tazawa R; Hagiwara K; Tsukada S; Miyawaki T; Tsuchiya S; Nukiwa T
    Respir Res; 2001; 2(3):188-92. PubMed ID: 11686883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic Aichi Virus Infection in a Patient with X-Linked Agammaglobulinemia.
    Bucciol G; Moens L; Payne K; Wollants E; Mekahli D; Levtchenko E; Vermeulen F; Tousseyn T; Gray P; Ma CS; Tangye SG; Van Ranst M; Brown JR; Breuer J; Meyts I
    J Clin Immunol; 2018 Oct; 38(7):748-752. PubMed ID: 30311057
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of a synonymous mutation in Btk in a patient with agammaglobulinemia: A case report.
    Srinivasan C; Shameli A; Ritchie B; Adatia A
    Immun Inflamm Dis; 2023 Oct; 11(10):e1049. PubMed ID: 37904676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study.
    Tóth B; Volokha A; Mihas A; Pac M; Bernatowska E; Kondratenko I; Polyakov A; Erdos M; Pasic S; Bataneant M; Szaflarska A; Mironska K; Richter D; Stavrik K; Avcin T; Márton G; Nagy K; Dérfalvi B; Szolnoky M; Kalmár A; Belevtsev M; Guseva M; Rugina A; Kriván G; Timár L; Nyul Z; Mosdósi B; Kareva L; Peova S; Chernyshova L; Gherghina I; Serban M; Conley ME; Notarangelo LD; Smith CI; van Dongen J; van der Burg M; Maródi L
    Mol Immunol; 2009 Jun; 46(10):2140-6. PubMed ID: 19419768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and mutational features of X-linked agammaglobulinemia in Mexico.
    García-García E; Staines-Boone AT; Vargas-Hernández A; González-Serrano ME; Carrillo-Tapia E; Mogica-Martínez D; Berrón-Ruíz L; Segura-Mendez NH; Espinosa-Rosales FJ; Yamazaki-Nakashimada MA; Santos-Argumedo L; López-Herrera G
    Clin Immunol; 2016 Apr; 165():38-44. PubMed ID: 26960951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical, immunological and genomic characteristics of children with X-linked agammaglobulinemia from Kerala, South India.
    Madathil Govindaraj G; Jain A; Edavazhippurath A; Bhoyar RC; Dhanasooraj D; Mishra A; Gupta V; Nair M; Shiny PM; Uppuluri R; Kumar A; Kashyap A; Ajith Kumar VT; Shankaran G; Senthivel V; Imran M; Kumar Divakar M; Sawant S; Dalvi A; Madkaikar M; Raj R; Sivasubbu S; Scaria V
    Hum Immunol; 2022 Apr; 83(4):335-345. PubMed ID: 35074268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant diagnosis of immune deficiency and
    Sanford E; Farnaes L; Batalov S; Bainbridge M; Laubach S; Worthen HM; Tokita M; Kingsmore SF; Bradley J
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus.
    Luk ADW; Ni K; Wu Y; Lam KT; Chan KW; Lee PP; Tu W; Mao H; Lau YL
    Front Immunol; 2018; 9():1826. PubMed ID: 30147693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?
    Çekiç Ş; Özgür T; Karalı Y; Özkan T; Kılıç SŞ
    Turk J Pediatr; 2019; 61(6):937-940. PubMed ID: 32134589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of amino acid substitution in the kinase domain of Bruton tyrosine kinase and its association with X-linked agammaglobulinemia.
    Mohammad T; Amir M; Prasad K; Batra S; Kumar V; Hussain A; Rehman MT; AlAjmi MF; Hassan MI
    Int J Biol Macromol; 2020 Dec; 164():2399-2408. PubMed ID: 32784026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia.
    Vu QV; Wada T; Le HT; Le HT; Van Nguyen AT; Osamu O; Yachie A; Nguyen SN
    BMC Pediatr; 2014 May; 14():129. PubMed ID: 24885015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.
    Pérez de Diego R; López-Granados E; Rivera J; Ferreira A; Fontán G; Bravo J; García Rodríguez MC; Bolland S
    Clin Exp Immunol; 2008 Apr; 152(1):33-8. PubMed ID: 18241233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
    Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemizygous BTK Gene Variant Causing X-Linked Agammaglobulinemia in Two Siblings.
    Saheb Sharif-Askari N; Hafezi S; Saheb Sharif-Askari F; Frommenwiler N; Halwani R
    J Clin Immunol; 2023 Oct; 43(7):1533-1536. PubMed ID: 37341860
    [No Abstract]   [Full Text] [Related]  

  • 59. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
    Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
    Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.
    Toker O; Broides A; Lev A; Simon AJ; Megged O; Shamriz O; Tal Y; Somech R; Lee YN; Nahum A
    Immunol Res; 2022 Apr; 70(2):216-223. PubMed ID: 35001352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.